Antibodies to human papillomavirus type 5 are generated in epidermal repair processes

Journal of Investigative Dermatology

Volumn 114, Issue 3, 2000, Pages 403-407

  Favre, Michel ^a   Majewski, Slavomir ^b   Noszczyk, Bartlomiej ^c   Maienfisch, Frédéric ^a   Pura, Anna ^b   Orth, Gérard ^a   Jablonska, Stefania ^b  

^a INSTITUT PASTEUR   (France)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Autoimmunity; Bullous diseases; Burn; Epidermal proliferation; Psoriasis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BULLOUS SKIN DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SCHOOL CHILD; VIRUS EXPRESSION; VIRUS TYPING; WART VIRUS;

EID: 0034087836     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00892.x     Document Type: Article

References (29)

1. Astori G, Lavergne D, Benton C, Hockmayr B, Egawa K, Garbe C, de Villiers EM: Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 110:752-755, 1998
2. Barbas SM, Ditzel HJ, Salonen EM, Yang WP, Silverman GJ, Burton DR: Human autoantibody recognition of DNA. Proc Natl Acad Sci USA 92:2529-2533, 1995
3. Berkhout RJM, Tieben LM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J: Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 33:690-695, 1995
4. Bernstein RM, Steigerwald JC, Tan EM: Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol 48:43-51, 1982
5. Beutner EH, Chorzelski TP, Jablonska S: Clinical significance of immunofluorescence tests of sera and skin in bullous diseases: a cooperative study. In: Beutner EH, Chorzelski TP, Kumar V (eds). Immunopathology of the Skin New York: John Wiley & Sons, 1987, pp. 177-205
6. Boxman ILA, Berkhout RJM, Mulder LHC, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J: Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 108:712-715, 1997
7. Boxman ILA, Mulder LHC, Russell A, Bouwes Bavinck JN, Green A, ter Schegget J: Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol 141:246-249, 1999
8. Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V: IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 420:325-334, 1983
9. Cohen LM, Karp Skopicki D, Harrist TJ, Clark WH Jr Noninfectious vesiculobullous and vesiculopustular diseases. In: Elder D, Elenitsas R, Jaworsky C, Johnson B (eds). Lever's Histopathology of the Skin, 8th edn. Philadelphia: Lippincott-Raven Publishers, 1997, pp. 209-252
10. de Villiers E-M: Human papillomavirus infections in skin cancers. Biomed Pharmacother 52:26-33, 1998
11. Favre M, Breitburd F, Croissant O, Orth G: Structural polypeptides of rabbit, bovine, and human papillomaviruses. J Virol 15:1239-1247, 1975
12. Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S: Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 110:311-317, 1998
13. Friedewald WF: Cell state as affecting susceptibility to a virus. Enhanced effectiveness of the rabbit papilloma virus on hyperplastic epidermis. J Exp Med 75:197-219, 1942
14. Greer CE, Peterson SL, Kiviat NB, Manos MM: PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 95:117-124, 1991
15. Griffiths CE, Voorhees JJ: Psoriasis. T cells and autoimmunity. J R Soc Med 89:315-319, 1996
16. Kawase M, Orth G, Jablonska S, Blanchet-Bardon C, Rueda L-A, Favre M: Variability and phylogeny of the L1 capsid protein gene of human papillomavirus type 5: contribution of clusters of nonsynonymous mutations and of a 30-nucleotide duplication. Virology 221:189-198, 1996
17. Kwok S. Procedures to minimize PCR-product carry-over. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR Protocols: a Guide to Methods and Applications. San Diego: Academic Press, 1990, pp. 142-145
18. Le Roy EC, Black C, Fleischmajer R, et al: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205, 1988
19. Majewski S, Jablonska S: Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 131:1312-1318, 1995
20. Majewski S, Favre M, Orth G, Jablonska S: Is human papillomavirus type 5 the putative autoantigen involved in psoriasis? J Invest Dermatol 111:541-542, 1998
21. Majewski S, Jablonska S, Favre M, Ramoz N, Orth G: Papillomavirus and autoimmunity in psoriasis. Immunol Today 20:475-476, 1999
22. Orth G. Epidermodysplasia verruciformis. In: Salzman NP, Howley PM (eds). The Papovaviridae: the Papillomaviruses, Vol 2. New York: Plenum Press, 1987, pp. 199-243
23. Pfister H, ter Schegget J: Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol 15:335-348, 1997
24. Ramoz N, Rueda L-A, Bouadjar B, Favre M, Orth G: A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 112:259-263, 1999
25. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H, de Villiers EM: Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 54:4610-4613, 1994
26. Shamanin V, zur Hausen H, Lavergne D, et al: Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Nat Cancer Inst 88:802-811, 1996
27. Stewart ACM, Eriksson AM, Manos MM, Muñoz N, Bosch FX, Peto J, Wheeler CM: Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol 70:3127-3136, 1996
28. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
29. Weissenborn SJ, Höpfl R, Weber F, Smola H, Pfister HJ, Fuchs PG: High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol 113:122-126, 1999